AF
ABBV icon

Apollon Financial’s AbbVie ABBV Stock Holding History

Apollon Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$384K Sell
1,524
-82
-5% -$17.6K 0.05% 226
2026
Q1 		$349K Sell
1,606
-779
-33% -$173K 0.05% 218
2025
Q4 		$545K Buy
2,385
+903
+61% +$206K 0.08% 169
2025
Q3 		$343K Buy
1,482
+215
+17% +$43.8K 0.06% 191
2025
Q2 		$235K Sell
1,267
-54
-4% -$10K 0.05% 195
2025
Q1 		$277K Buy
+1,321
New +$257K 0.07% 173
2024
Q4 		– Sell
-1,038
Closed -$205K – 187
2024
Q3 		$205K Buy
+1,038
New +$194K 0.06% 162

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Apollon Financial's ABBV Position: Q2 2026 in Review

Apollon Financial reduced its AbbVie (ABBV) stake by 5.1% in Q2 2026, selling an estimated $17.6K and leaving 1,524 shares worth $384K. The position accounts for 0.05% of the portfolio, ranked #226.

Apollon Financial first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $545K in Q4 2025. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Apollon Financial held 1,524 shares of AbbVie worth $384K as of Q2 2026.
  • Apollon Financial sold 82 AbbVie shares in Q2 2026, an estimated $17.6K.
  • AbbVie made up 0.05% of Apollon Financial's portfolio in Q2 2026, its #226 holding.
  • Apollon Financial first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Apollon Financial's AbbVie position peaked at $545K in Q4 2025.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Apollon Financial's 13F filing for Q2 2026, filed 23 Jul 2026.